Nat Myers Battles Stage IV Cancer, Determined to Keep Playing Music

Introduction

Blues artist Nat Myers, known for his deeply personal and critically acclaimed album Yellow Peril, is currently engaged in an arduous battle against Stage IV intimal sarcoma, a rare and aggressive cancer that has grown around his heart and pulmonary artery. The diagnosis, which came in February 2025, has profoundly impacted his life and career, forcing a stark confrontation with mortality. Despite the grim prognosis and the debilitating effects of treatment, Myers has demonstrated remarkable resilience, continuing to perform and record new music, driven by an unwavering passion for his art and a desire to inspire others.

Key Details

Diagnosis: Stage IV intimal sarcoma, a rare cancer affecting the heart and pulmonary artery, diagnosed in February 2025.
Initial Symptoms: Persistent back pain, initially attributed to touring lifestyle, later accompanied by breathing difficulties.
Treatment: Undergoing chemotherapy and radiation, with significant financial and physical tolls.
Musical Career: Released Yellow Peril in 2023, produced by Dan Auerbach, which explored themes of Asian-American identity and injustice.
Advocacy: Using his platform to raise awareness about healthcare access for musicians and combat health misinformation.
Current Status: Balancing treatment with touring and recording, with upcoming dates and new music projects planned.

Background

Born in Kansas and raised in Kentucky, Nat Myers’ musical journey began with a love for poetry before evolving into a deep connection with the blues. His heritage as a Korean-American in a predominantly white community often exposed him to prejudice, experiences that later fueled the lyrical content of his music. After studying poetry at The New School in New York, Myers found his voice not in academia, but on the streets, busking and earning his first money as a performer. This led to a burgeoning career, marked by his 2023 album Yellow Peril, a powerful reflection on racism and his identity, produced by Dan Auerbach. The album garnered significant attention, positioning Myers as a rising voice in contemporary blues and folk music. However, his promising trajectory was abruptly halted by the onset of severe pain in early 2025, which was eventually diagnosed as advanced cancer.

Impact Analysis

Myers' diagnosis has had a profound impact on his life, forcing him to confront his mortality while simultaneously navigating the complexities of the American healthcare system. The financial burden of treatment for an uninsured artist is immense, prompting him to launch a GoFundMe campaign. This situation underscores a critical issue within the music industry: the precarious financial and healthcare status of independent musicians, who often lack employer-sponsored benefits. Organizations like MusicCares and Music Health Alliance are vital resources, yet rising insurance premiums, exacerbated by the expiration of ACA subsidies, make access increasingly difficult. Myers' willingness to share his journey highlights the systemic failures and the urgent need for better healthcare solutions for artists.

“Grifters and charlatans come into the equation. If you were just a bird’s eye alien looking at America’s perspective of what cancer treatment is, you’d think the vast majority of Americans think it’s either a conspiracy, a sugar intake problem, or a parasite. You’d think the majority of Americans believe that, and it’s not true. I got a head on my shoulders, not to say other people don’t, but it’s a tragedy.”

Broader Context

Myers' fight against cancer occurs against a backdrop of rising cancer rates in certain demographics and persistent health disparities. His experience also brings into sharp focus the proliferation of health misinformation, particularly concerning cancer treatments. He expresses frustration with public figures who promote unproven or debunked remedies, drawing a stark contrast between evidence-based medicine and the dangerous allure of alternative therapies often found online. By documenting his own treatment journey, Myers aims to provide an authentic counter-narrative, encouraging others to seek reliable medical advice and to be wary of predatory influencers exploiting vulnerable patients. His story is a microcosm of a larger societal challenge in discerning credible health information in the digital age.

Future Outlook

Despite the setbacks, including a recent progression of his cancer requiring immediate radiation, Nat Myers remains resolutely focused on the future. He is already planning future performances, including a date at the Big Blues Bender in Las Vegas in 2027 and opening for Joy Oladokun in November. His commitment to creating new music is also unwavering, with recent studio sessions involving notable collaborators like producer Andrew Watt and members of the Red Hot Chili Peppers. Myers acknowledges that his voice and physical abilities may be impacted by his condition and treatment, but he is embracing potential changes, viewing them as part of his evolution as an artist. His determination to “kill this thing before it kills me” and his resilience in the face of adversity offer a powerful message of hope and perseverance.

Conclusion

Nat Myers' battle with Stage IV intimal sarcoma is a testament to the human spirit's capacity for resilience in the face of overwhelming odds. His journey from a promising blues musician to a public figure advocating for healthcare access and fighting misinformation is both inspiring and critical. By continuing to create and perform music amidst his treatment, Myers not only honors his artistic passion but also serves as a beacon of hope for others facing similar challenges. His story underscores the urgent need for systemic change in healthcare accessibility for independent artists and highlights the importance of critical thinking in navigating the complex landscape of health information. Myers’ unwavering resolve to “keep fighting like hell” ensures that his voice, both musically and advocacy-wise, will continue to resonate.